"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study to develop a device to help doctors understand more about blood clots in people with cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study was done to collect tissue samples and help develop a device that can give information about the cause of blood clots.
More about this trial
Deep vein thrombosis (DVT) is a blood clot that develops in the deep veins of the body. It is also sometimes called venous thromboembolism (VTE). Most blood clots can be treated, but they can be very serious if not.
We know that people with cancer have a higher risk of blood clots. This may be caused by the cancer itself, or by treatment such as chemotherapy or surgery.
This study was done to collect blood and tissue samples from women with ovarian cancer. The research team planned to use these samples to develop a way to find out more about what affects people’s risk of blood clots.
The aim of this study was to develop a device to help doctors look at tissue samples, and find out more about how and why blood clots develop.
Summary of results
How to join a clinical trial
Professor John Greenman
Hull and East Yorkshire NHS Trust
NIHR Clinical Research Network: Cancer